Acne Medication Market Size By Formulation (Topical, Oral), By Product (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Azelaic Acid), By Type (Prescription, OTC), By Acne Type (Inflammatory Acne, Non-Inflammatory Acne), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, E-commerce), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027
The acne medication market is expected to observe profitable growth by 2027 due to rising incidences of acne among the global population. Moreover, environmental conditions, such as pollution and harsh weather, can also promote acne, which is anticipated to support market growth over the following years.
After the COVID-19 outbreak, government and health agencies around the world instructed people, including healthcare workers and the general public, to wear masks in order to prevent the transmission of the novel coronavirus.
An October 2020 study explored the prevalent and potential risk factors to prevent face mask-related adverse skin reactions. The research findings indicated that acne was the most frequent adverse reaction among participants.
The study suggested that irritation caused while wearing a face mask, which increases the risk of pilosebaceous gland occlusion, might lead the skin to breakout. As a result, the increasing emphasis on face masks has played a key role in the mounting market demand across the globe.
The acne medication market has been segmented on the basis of formulation, type, product, acne type, distribution channel, and region. Based on formulation, the market has been bifurcated into topical and oral.
The oral sub-segment holds a significant share in the acne medication market and is anticipated to observe substantial growth at a CAGR of 6.3% through the forecast period. Oral acne medication offers higher effectivity and better results against inflammatory acne and nodular lesions, which is projected to fuel segmental growth through 2027.
In terms of product, the market has been categorized into antibiotics, retinoids, benzoyl peroxide, salicylic acid, azelaic acid, and others. The salicylic acid sub-segment was valued at above USD 1.4 billion in 2020 and is projected to progress at a significant pace over 2021-2027. High efficiency and suppressing power of salicylic acid against moderate to severe acne is estimated to boost product demand over the analysis period.
By type, the market has been divided into prescription and OTC. The prescription sub-segment is anticipated to witness robust growth at 5.7% CAGR through the forecast timeline due to increasing prevalence of severe and inflammatory acne globally.
On the basis of acne type, the market has been segregated into inflammatory acne and non-inflammatory acne. The non-inflammatory acne sub-segment valuation reached around USD 3.7 billion in 2020 and is projected to grow considerably by the end of 2027. Frequent occurrence of non-inflammatory acne across the globe is expected to support segmental expansion over the assessment period.
From the perspective of distribution channel, the market has been segmented into pharmacies & drug stores, retail stores, and e-commerce. In 2020, the e-commerce sub-segment valuation surpassed USD 1.8 billion and is speculated to progress at a steady growth rate over the projected timeline. Increasing preference for e-commerce by patients as well as healthcare professionals is expected to foster industry outlook through 2027.
On the regional spectrum, the Middle East & Africa acne medication market was valued at over USD 400 million in 2020 and is projected to witness stable growth at a CAGR of 4.9% over the study timeframe. Escalating awareness regarding acne treatment options across the countries in the region is anticipated to drive regional market growth over the analysis period.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook